Assessment of Hearing Ability in Patients after Head and Neck Cancer Radiotherapy

Introduction: The study assesses radiation-induced sensorineural hearing loss (SNHL) in head and neck cancer patients, highlighting the common occurrence of SNHL as a significant side effect of radiation therapy (RT) targeting the cochlea and acoustic pathways. Material and Methods: The study includ...

Full description

Saved in:
Bibliographic Details
Main Authors: Sohaila Yazdani, Kolsoum Teimouri, Negin Farshchian, Karim Khoshgard
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2024-10-01
Series:Iranian Journal of Medical Physics
Subjects:
Online Access:https://ijmp.mums.ac.ir/article_24302_0fa044fceee32acb9ccc81e6a5b7a16c.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832595674382729216
author Sohaila Yazdani
Kolsoum Teimouri
Negin Farshchian
Karim Khoshgard
author_facet Sohaila Yazdani
Kolsoum Teimouri
Negin Farshchian
Karim Khoshgard
author_sort Sohaila Yazdani
collection DOAJ
description Introduction: The study assesses radiation-induced sensorineural hearing loss (SNHL) in head and neck cancer patients, highlighting the common occurrence of SNHL as a significant side effect of radiation therapy (RT) targeting the cochlea and acoustic pathways. Material and Methods: The study included 34 patients (22 men, 12 women, mean age 40.13 ± 26.8 years) with head and neck cancers undergoing three-dimensional conformal radiation therapy (3D-CRT); 16 also had chemoradiotherapy (CRT). Pure-tone audiometry (PTA: 250-8000 Hz) was done before, immediately after, and three months post-RT for all patients. Hearing impairment was evaluated using the CTCAE 4.03 scoring system. Results: According to the findings, 19% and 37% of ears experienced SNHL immediately post-RT and 3 months after RT, respectively. The mean cochlear dose was 25.48 ± 13.56 Gy. A significant correlation existed between the cochlear dose and SNHL incidence (P-value < 0.05). Regression analysis indicated the mean cochlear dose as a robust predictor of SNHL, particularly at 8000 Hz (β = 0.570, P-value = 0.0001). Highest SNHL incidence at 8000 Hz, 3 months post-RT. A significant difference in SNHL threshold was observed between men and women at the frequency of 1000 Hz (P-value = 0.024). There was a statistically significant difference in SNHL thresholds between patients who underwent CRT versus those treated with RT alone (P-value < 0.05). Conclusion: RT commonly causes SNHL in head and neck cancer patients. Mean cochlear dose predicts SNHL, especially at higher frequencies.
format Article
id doaj-art-427f516431494be783bcd7c13d5c6c04
institution Kabale University
issn 2345-3672
language English
publishDate 2024-10-01
publisher Mashhad University of Medical Sciences
record_format Article
series Iranian Journal of Medical Physics
spelling doaj-art-427f516431494be783bcd7c13d5c6c042025-01-18T07:29:19ZengMashhad University of Medical SciencesIranian Journal of Medical Physics2345-36722024-10-0121533634210.22038/ijmp.2024.78841.239524302Assessment of Hearing Ability in Patients after Head and Neck Cancer RadiotherapySohaila Yazdani0Kolsoum Teimouri1Negin Farshchian2Karim Khoshgard3Students Research Committee, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.Students Research Committee, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, IranDepartment of Radiation Oncology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, IranAssociate Professor in Medical Physics, Department of Medical Physics, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, IranIntroduction: The study assesses radiation-induced sensorineural hearing loss (SNHL) in head and neck cancer patients, highlighting the common occurrence of SNHL as a significant side effect of radiation therapy (RT) targeting the cochlea and acoustic pathways. Material and Methods: The study included 34 patients (22 men, 12 women, mean age 40.13 ± 26.8 years) with head and neck cancers undergoing three-dimensional conformal radiation therapy (3D-CRT); 16 also had chemoradiotherapy (CRT). Pure-tone audiometry (PTA: 250-8000 Hz) was done before, immediately after, and three months post-RT for all patients. Hearing impairment was evaluated using the CTCAE 4.03 scoring system. Results: According to the findings, 19% and 37% of ears experienced SNHL immediately post-RT and 3 months after RT, respectively. The mean cochlear dose was 25.48 ± 13.56 Gy. A significant correlation existed between the cochlear dose and SNHL incidence (P-value < 0.05). Regression analysis indicated the mean cochlear dose as a robust predictor of SNHL, particularly at 8000 Hz (β = 0.570, P-value = 0.0001). Highest SNHL incidence at 8000 Hz, 3 months post-RT. A significant difference in SNHL threshold was observed between men and women at the frequency of 1000 Hz (P-value = 0.024). There was a statistically significant difference in SNHL thresholds between patients who underwent CRT versus those treated with RT alone (P-value < 0.05). Conclusion: RT commonly causes SNHL in head and neck cancer patients. Mean cochlear dose predicts SNHL, especially at higher frequencies.https://ijmp.mums.ac.ir/article_24302_0fa044fceee32acb9ccc81e6a5b7a16c.pdfhead and neck cancerradiation therapysensorineural hearing lossaudiometryside effects
spellingShingle Sohaila Yazdani
Kolsoum Teimouri
Negin Farshchian
Karim Khoshgard
Assessment of Hearing Ability in Patients after Head and Neck Cancer Radiotherapy
Iranian Journal of Medical Physics
head and neck cancer
radiation therapy
sensorineural hearing loss
audiometry
side effects
title Assessment of Hearing Ability in Patients after Head and Neck Cancer Radiotherapy
title_full Assessment of Hearing Ability in Patients after Head and Neck Cancer Radiotherapy
title_fullStr Assessment of Hearing Ability in Patients after Head and Neck Cancer Radiotherapy
title_full_unstemmed Assessment of Hearing Ability in Patients after Head and Neck Cancer Radiotherapy
title_short Assessment of Hearing Ability in Patients after Head and Neck Cancer Radiotherapy
title_sort assessment of hearing ability in patients after head and neck cancer radiotherapy
topic head and neck cancer
radiation therapy
sensorineural hearing loss
audiometry
side effects
url https://ijmp.mums.ac.ir/article_24302_0fa044fceee32acb9ccc81e6a5b7a16c.pdf
work_keys_str_mv AT sohailayazdani assessmentofhearingabilityinpatientsafterheadandneckcancerradiotherapy
AT kolsoumteimouri assessmentofhearingabilityinpatientsafterheadandneckcancerradiotherapy
AT neginfarshchian assessmentofhearingabilityinpatientsafterheadandneckcancerradiotherapy
AT karimkhoshgard assessmentofhearingabilityinpatientsafterheadandneckcancerradiotherapy